日本新薬 revises consolidated earnings forecast for the fiscal year ending March 2027 downward (under IFRS) [DZH Individual Stock Information] (Jiji Press)

The story

日本新薬 announced a downward revision to its consolidated earnings forecast for the fiscal year ending March 2027.

Under IFRS, consolidated operating profit for the period is expected to reach ¥33.0 billion.

At a glance

CompanyNippon Shinyaku

PeriodFiscal year ending March 2027

TypeConsolidated operating profit forecast to be positive

Amount¥33.0 billion profit expected

Accounting standardApplication of IFRS

Reference information. Every claim resolves to something the story actually named.

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

finance.yahoo.co.jpNews

AgreesOpen

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.